concept life sciences integrated discovery & development services limited

Live MatureLargeHealthy

concept life sciences integrated discovery & development services limited Company Information

Share CONCEPT LIFE SCIENCES INTEGRATED DISCOVERY & DEVELOPMENT SERVICES LIMITED

Company Number

02345676

Shareholders

concept life sciences (discovery) ltd

Group Structure

View All

Industry

Other research and experimental development on natural sciences and engineering

 

Registered Address

concept life sciences, frith knoll road, chapel-en-le-frith, high peak, SK23 0PG

concept life sciences integrated discovery & development services limited Estimated Valuation

£37.4m

Pomanda estimates the enterprise value of CONCEPT LIFE SCIENCES INTEGRATED DISCOVERY & DEVELOPMENT SERVICES LIMITED at £37.4m based on a Turnover of £21.9m and 1.71x industry multiple (adjusted for size and gross margin).

concept life sciences integrated discovery & development services limited Estimated Valuation

£0

Pomanda estimates the enterprise value of CONCEPT LIFE SCIENCES INTEGRATED DISCOVERY & DEVELOPMENT SERVICES LIMITED at £0 based on an EBITDA of £-194.9k and a 8.09x industry multiple (adjusted for size and gross margin).

concept life sciences integrated discovery & development services limited Estimated Valuation

£0

Pomanda estimates the enterprise value of CONCEPT LIFE SCIENCES INTEGRATED DISCOVERY & DEVELOPMENT SERVICES LIMITED at £0 based on Net Assets of £-3.2m and 1.93x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Concept Life Sciences Integrated Discovery & Development Services Limited Overview

Concept Life Sciences Integrated Discovery & Development Services Limited is a live company located in chapel-en-le-frith, SK23 0PG with a Companies House number of 02345676. It operates in the other research and experimental development on natural sciences and engineering sector, SIC Code 72190. Founded in February 1989, it's largest shareholder is concept life sciences (discovery) ltd with a 100% stake. Concept Life Sciences Integrated Discovery & Development Services Limited is a mature, large sized company, Pomanda has estimated its turnover at £21.9m with healthy growth in recent years.

View Sample
View Sample
View Sample

Upgrade for unlimited company reports & a free credit check

Concept Life Sciences Integrated Discovery & Development Services Limited Health Check

Pomanda's financial health check has awarded Concept Life Sciences Integrated Discovery & Development Services Limited a 3 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 5 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating3out of 5
positive_score

5 Strong

positive_score

2 Regular

positive_score

5 Weak

size

Size

annual sales of £21.9m, make it larger than the average company (£4.4m)

£21.9m - Concept Life Sciences Integrated Discovery & Development Services Limited

£4.4m - Industry AVG

growth

Growth

3 year (CAGR) sales growth of 12%, show it is growing at a faster rate (6.7%)

12% - Concept Life Sciences Integrated Discovery & Development Services Limited

6.7% - Industry AVG

production

Production

with a gross margin of 46.4%, this company has a comparable cost of product (47.1%)

46.4% - Concept Life Sciences Integrated Discovery & Development Services Limited

47.1% - Industry AVG

profitability

Profitability

an operating margin of -11.7% make it less profitable than the average company (3.6%)

-11.7% - Concept Life Sciences Integrated Discovery & Development Services Limited

3.6% - Industry AVG

employees

Employees

with 291 employees, this is above the industry average (46)

291 - Concept Life Sciences Integrated Discovery & Development Services Limited

46 - Industry AVG

paystructure

Pay Structure

on an average salary of £44.1k, the company has a lower pay structure (£64.5k)

£44.1k - Concept Life Sciences Integrated Discovery & Development Services Limited

£64.5k - Industry AVG

efficiency

Efficiency

resulting in sales per employee of £75.2k, this is less efficient (£124k)

£75.2k - Concept Life Sciences Integrated Discovery & Development Services Limited

£124k - Industry AVG

debtordays

Debtor Days

it gets paid by customers after 56 days, this is near the average (55 days)

56 days - Concept Life Sciences Integrated Discovery & Development Services Limited

55 days - Industry AVG

creditordays

Creditor Days

its suppliers are paid after 35 days, this is quicker than average (44 days)

35 days - Concept Life Sciences Integrated Discovery & Development Services Limited

44 days - Industry AVG

stockdays

Stock Days

it holds stock equivalent to 12 days, this is less than average (123 days)

12 days - Concept Life Sciences Integrated Discovery & Development Services Limited

123 days - Industry AVG

cashbalance

Cash Balance

has cash to cover current liabilities for 2 weeks, this is less cash available to meet short term requirements (31 weeks)

2 weeks - Concept Life Sciences Integrated Discovery & Development Services Limited

31 weeks - Industry AVG

debtlevel

Debt Level

it has a ratio of liabilities to total assets of 113.9%, this is a higher level of debt than the average (44.4%)

113.9% - Concept Life Sciences Integrated Discovery & Development Services Limited

44.4% - Industry AVG

CONCEPT LIFE SCIENCES INTEGRATED DISCOVERY & DEVELOPMENT SERVICES LIMITED financials

EXPORTms excel logo

Concept Life Sciences Integrated Discovery & Development Services Limited's latest turnover from December 2023 is £21.9 million and the company has net assets of -£3.2 million. According to their latest financial statements, Concept Life Sciences Integrated Discovery & Development Services Limited has 291 employees and maintains cash reserves of £965.7 thousand as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Mar 2014Mar 2013Mar 2012Mar 2011Mar 2010
Turnover21,872,48024,008,52620,134,35315,666,75816,658,53314,084,17413,352,0408,800,0228,269,9714,678,8189,185,0229,107,7639,083,1068,700,4727,523,952
Other Income Or Grants
Cost Of Sales11,714,34612,732,05010,260,3368,290,0867,908,4017,787,7555,572,7403,860,4453,771,9363,044,0424,681,0185,120,1965,145,6525,103,9894,357,941
Gross Profit10,158,13411,276,4769,874,0177,376,6728,750,1326,296,4197,779,3004,939,5774,498,0351,634,7764,504,0043,987,5673,937,4543,596,4833,166,011
Admin Expenses12,710,69410,450,24011,685,9219,628,46111,845,78012,973,6315,767,6934,322,7723,965,3602,394,9903,766,5563,965,4293,662,8523,425,8972,905,179
Operating Profit-2,552,560826,236-1,811,904-2,251,789-3,095,648-6,677,2122,011,607616,805532,675-760,214737,44822,138274,602170,586260,832
Interest Payable216,733262,997147,396190,21543,60525,3991,30510,07010,89718,60550,81328,41671,335137,826161,293
Interest Receivable1,4131,4136638731,0472,106815
Pre-Tax Profit-1,355,244563,239-1,959,300-2,442,004-3,139,253-6,702,6112,010,302606,735522,248-293,805637,915634207,09111,598100,673
Tax72,822485,1401,120,902507,997473,336-622,780-137,627-58,832218,587268,818197,199335,393636,046215,762
Profit After Tax-1,355,244636,061-1,474,160-1,321,102-2,631,256-6,229,2751,387,522469,108463,416-75,218906,733197,833542,484647,644316,435
Dividends Paid80,52125,180150,09948,419
Retained Profit-1,355,244636,061-1,474,160-1,321,102-2,631,256-6,229,2751,387,522469,108463,416-75,218826,212172,653392,385599,225316,435
Employee Costs12,829,14112,806,12211,152,5678,524,7829,892,4489,048,4406,641,9814,871,6534,734,9342,704,7805,286,8065,474,6475,703,8795,547,3924,317,892
Number Of Employees291298262200201205212118133104146148158159127
EBITDA*-194,9483,110,736303,470-517,350-1,678,982-5,841,6902,493,998969,118849,732-544,5641,044,860386,347726,600684,251872,940

* Earnings Before Interest, Tax, Depreciation and Amortisation

Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Mar 2014Mar 2013Mar 2012Mar 2011Mar 2010
Tangible Assets8,926,89015,509,93515,240,90414,362,87011,878,2736,040,3085,688,7604,364,5174,444,1774,367,4654,497,6514,639,8724,946,0045,300,8795,663,665
Intangible Assets2,670,0747,27418,52737,054
Investments & Other430,83412,80312,80312,80312,80312,80312,80312,80312,80312,80349,38349,38349,38349,383
Debtors (Due After 1 year)418,031573,209577,220114,999
Total Fixed Assets12,027,79815,091,90414,667,69513,785,65011,763,2746,040,3085,701,5634,377,3204,456,9804,380,2684,497,6514,696,5294,995,3875,368,7895,750,102
Stock & work in progress402,558635,223496,354390,513525,617497,3991,101,621234,048261,64950,3001,086,4811,191,8151,243,6381,216,946942,280
Trade Debtors3,361,4593,201,2323,051,0352,891,0443,021,9832,112,8712,496,1681,494,042717,349855,157991,720547,718797,929771,502747,082
Group Debtors2,902,6943,123,09418,870599,6025,406,0662,159,9211,379,880535,997
Misc Debtors3,042,1503,913,5293,129,1934,081,4682,536,4452,938,1981,916,1951,448,8921,188,491536,790938,124826,042681,451681,857831,416
Cash965,6821,647,4931,371,633803,824581,792380,699332,207465,430702,59341,274783,917375,047854,9271,233,139
misc current assets2,2292,2292,2292,2292,3308,9918,9918,9918,9918,991
total current assets10,674,5439,397,4778,048,21510,486,1197,872,4036,732,09111,302,9785,671,3394,015,0282,683,1673,066,5903,358,4833,107,0563,534,2233,762,908
total assets22,702,34124,489,38122,715,91024,271,76919,635,67712,772,39917,004,54110,048,6598,472,0087,063,4357,564,2418,055,0128,102,4438,903,0129,513,010
Bank overdraft15,053
Bank loan25,107255,288256,171251,752247,414
Trade Creditors 1,127,445900,005914,921969,4981,400,4681,053,3631,555,894619,577672,401313,805593,252420,084275,026619,152237,357
Group/Directors Accounts19,188,2034,821,875994,375398,99912,903
other short term finances2,89264,647109,390309,390759,390
hp & lease commitments569,127700,5201,068,680538,0991,171,99487,43525,6423,79235,96237,17338,48317,862109,907148,924196,910
other current liabilities2,651,94921,113,09319,083,60818,470,78913,597,5109,086,7771,688,2741,155,539555,650301,639350,9241,636,2001,562,9561,580,6841,715,539
total current liabilities23,536,72422,713,61821,067,20919,978,38616,169,97210,227,5758,091,6852,773,2831,663,012680,5731,010,6582,394,0812,313,4502,909,9023,156,610
loans6,283,5167,303,63410,117,1048,071,510222,4021,127262,230626,929981,540
hp & lease commitments2,318,8503,141,7583,651,8175,058,5524,035,755111,201200,7422,72840,01067,56726,277133,700339,875
Accruals and Deferred Income431,994431,994195,78169,798
other liabilities
provisions49,21693,821495,550
total long term liabilities2,318,8503,573,7524,083,8115,254,3334,105,553111,201249,9582,72840,01067,5671,127288,507854,4501,816,965
total liabilities25,855,57426,287,37025,151,02025,232,71920,275,52510,338,7768,341,6432,773,2831,665,740720,5831,078,2252,395,2082,601,9573,764,3524,973,575
net assets-3,153,233-1,797,989-2,435,110-960,950-639,8482,433,6238,662,8987,275,3766,806,2686,342,8526,486,0165,659,8045,500,4865,138,6604,539,435
total shareholders funds-3,153,233-1,797,989-2,435,110-960,950-639,8482,433,6238,662,8987,275,3766,806,2686,342,8526,486,0165,659,8045,500,4865,138,6604,539,435
Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Mar 2014Mar 2013Mar 2012Mar 2011Mar 2010
Operating Activities
Operating Profit-2,552,560826,236-1,811,904-2,251,789-3,095,648-6,677,2122,011,607616,805532,675-760,214737,44822,138274,602170,586260,832
Depreciation1,731,7092,284,5002,115,3741,734,4391,416,666835,522482,391352,313317,057215,650307,412364,209433,471495,138514,765
Amortisation625,90318,52718,52797,343
Tax72,822485,1401,120,902507,997473,336-622,780-137,627-58,832218,587268,818197,199335,393636,046215,762
Stock-232,665138,869105,841-135,10428,218-604,222867,573-27,601211,349-1,141,515-105,334-51,82326,692274,666942,280
Debtors1,773,511779,355-3,919,3894,980,52941,626-4,167,7584,715,5741,817,1351,357,776554,184556,084-105,62026,021-125,1391,578,498
Creditors227,440-14,916-54,577-430,970347,105-502,531936,317-52,824358,596-106,279173,168145,058-344,126381,795237,357
Accruals and Deferred Income-18,893,1382,029,485849,0324,999,2624,580,5317,398,503532,735599,889254,011-1,334,561-1,285,27673,244-17,728-134,8551,715,539
Deferred Taxes & Provisions-49,21649,216-93,821-401,729495,550
Cash flow from operations-20,401,4924,279,9035,396,613326,4193,686,8076,250,382-2,193,661-410,978-165,618-1,179,486-249,180959,291553,6051,015,9811,016,370
Investing Activities
capital expenditure1,555,359-2,553,531-2,993,408-4,219,036-7,254,631-1,187,070-1,806,634-272,653-393,76964,031-89,493-65,351-78,596-132,352-148,410
Change in Investments418,031-36,580-49,38349,383
cash flow from investments1,137,328-2,553,531-2,993,408-4,219,036-7,254,631-1,187,070-1,806,634-272,653-393,769100,611-40,110-65,351-78,596-132,352-197,793
Financing Activities
Bank loans-255,288-230,181-8834,4194,338247,414
Group/Directors Accounts19,188,203-4,821,8753,827,500595,376386,09612,903
Other Short Term Loans -64,647-61,755-44,743-200,000-450,000759,390
Long term loans-6,283,516-1,020,118-2,813,4702,045,5947,849,108222,402-1,127-1,127-261,103-364,699-354,611981,540
Hire Purchase and Lease Commitments-954,301-878,219-876,154388,9025,009,113-27,748222,592-34,898-38,49359,32188,188-118,322-146,440-254,161536,785
other long term liabilities
share issue1,0601,000,000-442,215758,266-13,335-30,5594,223,000
interest-216,733-262,997-147,396-190,215-43,605-25,399-1,305-10,070-9,484-17,192-50,150-27,543-70,288-135,720-160,478
cash flow from financing11,733,653-2,160,274-3,837,0203,244,28112,372,401-4,652,6204,048,787550,408338,119492,236-255,025-465,929-807,567-1,190,1546,587,651
cash and cash equivalents
cash-681,811275,8601,371,633-803,824222,032201,09348,492-133,223-237,163-81,324-742,643408,870-479,880-378,2121,233,139
overdraft-15,05315,053
change in cash-681,811275,8601,371,633-803,824222,032201,09348,492-133,223-222,110-96,377-742,643408,870-479,880-378,2121,233,139

concept life sciences integrated discovery & development services limited Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for concept life sciences integrated discovery & development services limited. Get real-time insights into concept life sciences integrated discovery & development services limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Concept Life Sciences Integrated Discovery & Development Services Limited Competitor Analysis

competitor_analysis_table_img

Perform a competitor analysis for concept life sciences integrated discovery & development services limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other large companies, companies in SK23 area or any other competitors across 12 key performance metrics.

concept life sciences integrated discovery & development services limited Ownership

CONCEPT LIFE SCIENCES INTEGRATED DISCOVERY & DEVELOPMENT SERVICES LIMITED group structure

Concept Life Sciences Integrated Discovery & Development Services Limited has 2 subsidiary companies.

Ultimate parent company

2 parents

CONCEPT LIFE SCIENCES INTEGRATED DISCOVERY & DEVELOPMENT SERVICES LIMITED

02345676

2 subsidiaries

CONCEPT LIFE SCIENCES INTEGRATED DISCOVERY & DEVELOPMENT SERVICES LIMITED Shareholders

concept life sciences (discovery) ltd 100%

concept life sciences integrated discovery & development services limited directors

Concept Life Sciences Integrated Discovery & Development Services Limited currently has 2 directors. The longest serving directors include Mr Matthew Hanson (Aug 2019) and Dr Benjamin Cliff (Mar 2023).

officercountryagestartendrole
Mr Matthew HansonUnited Kingdom41 years Aug 2019- Director
Dr Benjamin Cliff47 years Mar 2023- Director

P&L

December 2023

turnover

21.9m

-9%

operating profit

-2.6m

-409%

gross margin

46.5%

-1.12%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

December 2023

net assets

-3.2m

+0.75%

total assets

22.7m

-0.07%

cash

965.7k

-0.41%

net assets

Total assets minus all liabilities

concept life sciences integrated discovery & development services limited company details

company number

02345676

Type

Private limited with Share Capital

industry

72190 - Other research and experimental development on natural sciences and engineering

incorporation date

February 1989

age

36

incorporated

UK

ultimate parent company

accounts

Audit Exemption Subsidiary

last accounts submitted

December 2023

previous names

peakdale molecular limited (September 2017)

peakdale technologies limited (July 2001)

See more

accountant

HAZLEWOODS LLP

auditor

-

address

concept life sciences, frith knoll road, chapel-en-le-frith, high peak, SK23 0PG

Bank

NATIONAL WESTMINSTER BANK PLC

Legal Advisor

-

concept life sciences integrated discovery & development services limited Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We found 7 charges/mortgages relating to concept life sciences integrated discovery & development services limited. Currently there are 1 open charges and 6 have been satisfied in the past.

concept life sciences integrated discovery & development services limited Capital Raised & Share Issues BETA

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for CONCEPT LIFE SCIENCES INTEGRATED DISCOVERY & DEVELOPMENT SERVICES LIMITED. This can take several minutes, an email will notify you when this has completed.

concept life sciences integrated discovery & development services limited Companies House Filings - See Documents

datedescriptionview/download